僅用于工業應用或科學研究，不可用于人類或動物的臨床診斷或治療，非藥用. Tanezumab （RN-624） is a humanized anti-NGF mAb with high affinity and specificity. Tanezumab blocks NGF binding to its receptors, p75 and TrkA, in the peripheral nervous system. Tanezumab can be used in studies of acute and chronic pain such as osteoarthritis, knee and neuralgia, as well as post-herpetic neuralgia